Healthcare

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.

Exploiting ETH Zurich research, Micreos is working on a clinical platform that enables the targeted killing of unwanted bacteria only.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Humboldt State University has joined forces with UC Davis to create an incubator focused on agtech and biotech companies in northern California.

Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.

Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.

ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.

Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.